Treating depression among patients with chronic prescription opioid use may help wean the patients off opioids, according to a study published in the British Journal of Psychiatry. Researchers used ...
Patients who increased doses of opioid medicines to manage chronic pain were more likely to experience an increase in depression, according to Saint Louis University findings in Pain. The study, ...
A clinical trial of an experimental drug for treatment-resistant major depression finds that modulation of the endogenous opioid system may improve the effectiveness of drugs that target the action of ...
Opioids are still widely prescribed, but have limited effectiveness and are associated with serious harms. De-prescribing ...
Ingesting just one oxycodone tablet and moderately consuming alcohol can increase the risk of respiratory depression, a potentially fatal side effect caused by drug overdose, according to a new study ...
Washington D.C. [USA], Oct 4 (ANI): According to a recent study, there is a strong link between mental health disorders and substance abuse. "For every additional 1 per cent of the population that has ...
This head-to-head pharmacodynamic study in healthy volunteers examined the ability of both OPVEE and intranasal naloxone to reverse opioid-induced respiratory depression, which is the shallow and slow ...
STAMFORD, Conn.--(BUSINESS WIRE)--Purdue Pharma L.P. (“Purdue”) today announced The Journal of Clinical Pharmacology has published findings from a study in healthy adult volunteers that demonstrated ...
Nitazene was first developed in the 1950s as an analgesic, but was never approved for medical use. Instead, it was “limited ...
A class of synthetic drugs called nitazines have been around since the 1950s — but are quickly gaining a foothold in street drugs.
Greater access to cannabis correlated with significant reductions in opioid prescriptions for people with cancer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback